Trial Profile
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2014
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Sleep apnoea syndrome
- Focus Pharmacodynamics
- Acronyms StatinflaSAS
- 10 Nov 2014 New trial record